2016
DOI: 10.7554/elife.16381
|View full text |Cite
|
Sign up to set email alerts
|

The molecular basis for ANE syndrome revealed by the large ribosomal subunit processome interactome

Abstract: ANE syndrome is a ribosomopathy caused by a mutation in an RNA recognition motif of RBM28, a nucleolar protein conserved to yeast (Nop4). While patients with ANE syndrome have fewer mature ribosomes, it is unclear how this mutation disrupts ribosome assembly. Here we use yeast as a model system and show that the mutation confers growth and pre-rRNA processing defects. Recently, we found that Nop4 is a hub protein in the nucleolar large subunit (LSU) processome interactome. Here we demonstrate that the ANE synd… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
16
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(19 citation statements)
references
References 38 publications
3
16
0
Order By: Relevance
“…However, because many RBPs contain two or more RRMs, a single missense mutation may not abolish RNA binding or intramolecular contacts completely and may still be compatible with life. Unlike RRM1, tested UHM substitutions in PD invariably reduced PUF60 expression (Figure 7I ), possibly through impaired folding, as shown for a RRM3 substitution in RBM28 in the ANE syndrome ( 119 ). Tested residues mutated in PD lack known post-translation modifications and all (except for E181) had a predicted accessible surface area below 30% ( http://www.phosphosite.org ; http://dbptm.mbc.ntcu.edu ).…”
Section: Discussionmentioning
confidence: 64%
“…However, because many RBPs contain two or more RRMs, a single missense mutation may not abolish RNA binding or intramolecular contacts completely and may still be compatible with life. Unlike RRM1, tested UHM substitutions in PD invariably reduced PUF60 expression (Figure 7I ), possibly through impaired folding, as shown for a RRM3 substitution in RBM28 in the ANE syndrome ( 119 ). Tested residues mutated in PD lack known post-translation modifications and all (except for E181) had a predicted accessible surface area below 30% ( http://www.phosphosite.org ; http://dbptm.mbc.ntcu.edu ).…”
Section: Discussionmentioning
confidence: 64%
“…However, yeast has no known equivalent of p53 and is therefore well-suited for investigating the interaction between ribosome formation and cell cycle progression in the absence of p53. Indeed, the mechanisms for several ribosomopathies have recently been modeled in yeast by mutating yeast equivalents of human ribosomopathy genes [ 32 34 ] supporting the competency of yeast as a disease model for ribosomopathies.…”
Section: Introductionmentioning
confidence: 99%
“…Though not fully understood, tissue-specific defects are the hallmark of ribosomopathies (11,17). Tissues formed from hematopoietic or neural crest cell lineages are disproportionately affected, resulting in anemia, neutropenia, and leukemia, bone marrow failure diseases including Diamond-Blackfan Anemia (DBA) (18)(19)(20)(21)(22)(23) and Shwachman-Diamond syndrome (24)(25)(26), craniofacial, dermatological, and neurological diseases including Treacher Collins syndrome (27)(28)(29) and postaxial acrofacial dysostosis (30), and alopecia, neurologic defects, and endocrinopathy (ANE) syndrome (31)(32)(33)(34).…”
mentioning
confidence: 99%
“…Nop4 (36)(37)(38)(39). Follow-up studies further defined the clinical extent of endocrinopathy (32) and the biochemical mechanisms of hair and skin defects (33) and of inhibited ribosome biogenesis (34,40) due to impaired function of RBM28 or its yeast homolog, Nop4. However, due to the rarity of the disease and lack of sufficient animal model studies, further investigation of ANE syndrome has been limited.…”
mentioning
confidence: 99%